Litronesib Completed Phase 1 Trials for Cancer, Advanced / Metastatic Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01214629A Study for Participants With Advanced Cancer